Global IgA Nephropathy Market Analysis By Diagnosis (Iothalamate Clearance Test, Kidney Biopsy, Blood Tests, Urine Tests), By Diseases Type (Primary IgA Nephropathy, Secondary IgA Nephropathy), By Systems (Hematuria, Proteinuria, Edema, Others), By Population Type (Pediatrics, Adults), By Route of Administration (Oral, Parenteral, Others), By End Users (Hospitals, Specialty Clinics, Homecare, Others) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Jan 2025
- Report ID: 136838
- Number of Pages: 291
- Format:
-
keyboard_arrow_up
-
-
- Astellas Pharma Inc.
- Kyowa Kirin Co. Ltd.
- Merck Co. Inc.
- Pfizer Inc Company Profile
- Johnson Johnson Services Inc.
- Novartis AG Company Profile
- Baxter International Inc.
- Fresenius Medical Care AG Co. KGaA
- Otsuka Pharmaceutical Co. Ltd.
- AbbVie Inc. Company Profile
- Bristol-Myers Squibb Company
- Chugai Pharmaceutical Co. Ltd.
- HoffmannLa Roche Ltd.
- settingsSettings
Our Clients
- 136838
- Jan 2025
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
